Does Pazopanib 200 Mg Tablet Antineoplastic - Protein-Tyrosine Kinase Inhibitors Interact with other Medications?
Severe Interactions
These medications are not usually taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED IMMUNOSUPPRESSANTS/NADOFARAGENE FIRADENOVEC
- WEAK CYP3A4 INHIBITORS/LEMBOREXANT (> 5 MG)
- WEAK CYP3A4 INHIBITORS/LOMITAPIDE (>30 MG)
- SELECTED IMMUNOSUPPRESSANTS/TALIMOGENE LAHERPAREPVEC
- SELECTED IMMUNOSUPPRESSIVE AGENTS/LIVE VACCINES; LIVE BCG
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/EFALIZUMAB; NATALIZUMAB
- UGT1A1 INHIBITORS/IRINOTECAN
Serious Interactions
These medications may interact and cause very harmful effects. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SLT ANTINEOPLASTIC SYSTEMIC ENZYME INHIB/ST. JOHN'S WORT
- SELECTED KINASE INHIBITORS/PROTON PUMP INHIBITORS
- SLT ANTINEO SYSTEMIC ENZYME INHIBITORS/FLUCONAZOLE
- PAZOPANIB/SELECTED INHIBITORS OF P-GP OR BCRP
- DASATINIB; PAZOPANIB/H2 ANTAGONISTS
- SELECTED ANTINEOPLASTICS THAT PROLONG QT/SAQUINAVIR
- PAZOPANIB/P-GP OR BCRP INHIBITORS THAT PROLONG QT
- SELECTED P-GLYCOPROTEIN (P-GP) SUBSTRATES/LORLATINIB
- PAZOPANIB/QT PROLONGING AGENTS
- PAZOPANIB/STRONG CYP3A4 INHIBITORS
- PAZOPANIB/STRONG CYP3A4 INHIBITORS THAT PROLONG QT
- PAZOPANIB/LONAFARNIB
- ANTINEOPLASTIC SYSTEMIC ENZYME INHIBITORS/CARBAMAZEPINE
- ANTINEOPLASTIC SYST ENZYME INHIBITORS/APALUTAMIDE
- SLT ANTINEOPLASTIC SYSTEMIC ENZYME INH/LUMACAFTOR-IVACAFTOR
- PAZOPANIB/VONOPRAZAN-CLARITHROMYCIN
- SELECTED KINASE INHIBITORS/VONOPRAZAN
- PAZOPANIB/STRONG CYP3A4 INDUCERS
- PAZOPANIB/STRONG CYP3A4 INDUCERS THAT PROLONG QT
- PAZOPANIB/ENCORAFENIB
- IMMUNOSUPPRESSIV; IMMUNOMODULATORS THAT PROLONG QT/ETRASIMOD
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/RITLECITINIB
- SELECT UGT INHIBITORS/PEXIDARTINIB
- PAZOPANIB/TACROLIMUS
- UGT INHIBITORS/LORAZEPAM EXTENDED RELEASE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/CLADRIBINE
- IMMUNOSUPPRESSIV; IMMUNOMODULATORS THAT PROLONG QT/SIPONIMOD
- IMMUNOSUPPRESSIVES;IMMUNOMODULATORS THAT PROLONG QT/OZANIMOD
- IMMUNOSUPPRES;IMMUNOMODULATORS THAT PROLONG QT/FINGOLIMOD
- IMMUNOSUPPRESSIV;IMMUNOMODULATORS THAT PROLONG QT/PONESIMOD
- MYELOSUPPRESSIVES; IMMUNOMODULATORS/SODIUM IODIDE I 131
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/FILGOTINIB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/BARICITINIB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/INEBILIZUMAB
- UGT1A1 INHIBITORS/SACITUZUMAB GOVITECAN
- MYELOSUPPRESSIVE AGENTS THAT PROLONG QT/CLOZAPINE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/UPADACITINIB
- SELECT UGT INHIBITORS/PEXIDARTINIB (200 MG)
- WEAK CYP3A4 INHIBITORS/ELIGLUSTAT
- POSSIBLE QT PROLONGING AGENTS/DOMPERIDONE
- IMMUNOSUPPRES;IMMUNOMODUL/SELECTED MULTIPLE SCLEROSIS AGENTS
- STRONG UGT1A1 INHIBITORS/BELINOSTAT
- POSSIBLE QT PROLONGING AGENTS/ANAGRELIDE
- WEAK CYP3A4 INHIBITORS/LOMITAPIDE (<=30MG)
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/TOFACITINIB
- SELECTED MYELOSUPPRESSIVE AGENTS/DEFERIPRONE
- POSSIBLE QT PROLONGING AGENTS/ARTEMETHER-LUMEFANTRINE
- POSSIBLE QT PROLONGING AGENTS/DISOPYRAMIDE
- POSSIBLE QT PROLONGING AGENTS/CISAPRIDE
- SELECTED QT PROLONGING AGENTS/ZIPRASIDONE
- POSSIBLE QT PROLONGING AGENTS/SERTINDOLE
- POSSIBLE QT PROLONGING AGENTS/DROPERIDOL
- POSSIBLE QT PROLONGING AGENTS/LEVOMETHADYL
- POSSIBLE QT PROLONGING AGENTS/SPARFLOXACIN
- POSSIBLE QT PROLONGING AGENTS/HALOFANTRINE
- POSSIBLE QT PROLONGING AGENTS/PIMOZIDE
- POSSIBLE QT PROLONGING AGENTS/BEPRIDIL
Moderate Interactions
These medications may cause some risk when taken together. Consult your healthcare professional (e.g., doctor or pharmacist) for more in formation.
- SELECTED KINASE INHIBITORS/ANTACIDS
- PAZOPANIB/POSSIBLE QT PROLONGING AGENTS
- SELECTED P-GLYCOPROTEIN (P-GP) SUBSTRATES/IBRUTINIB
- POSSIBLE QT PROLONGING AGENTS/DEXMEDETOMIDINE SUBLINGUAL
- QT PROLONGING AGENTS/GEPIRONE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/TOCILIZUMAB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/UBLITUXIMAB
- QT PROLONGING AGENTS/TUCIDINOSTAT
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/SARILUMAB
- QT PROLONGING AGENTS/TRICLABENDAZOLE
- POSSIBLE QT PROLONGING AGENTS/PACRITINIB
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/COVID-19 VACCINES
- POSSIBLE QT PROLONGING AGENTS/FEXINIDAZOLE
- QT PROLONGING AGENTS/GALANTAMINE
- POSSIBLE QT PROLONGING AGENTS/LEVOMEPROMAZINE
- IMMUNOSUPPRESSIVES; IMMUNOMODULATORS/USTEKINUMAB
- QT PROLONGING AGENTS/OSILODROSTAT
- QT PROLONGING AGENTS/AMISULPRIDE
- WEAK CYP3A4 INHIBITORS/UBROGEPANT
- WEAK CYP3A4 INHIBITORS/LEMBOREXANT (<= 5 MG)
- POSSIBLE QT PROLONGING AGENTS/LEFAMULIN
- POSSIBLE QT PROLONGING AGENTS/ENTRECTINIB
- PAZOPANIB/HMG CO-A REDUCTASE INHIBITORS
- QT PROLONGING AGENTS/PITOLISANT
- QT PROLONGING AGENTS/GILTERITINIB
- POSSIBLE QT PROLONGING AGENTS/GLASDEGIB
- POSSIBLE QT PROLONGING AGENTS/TRAZODONE (< 100 MG)
- POSSIBLE QT PROLONGING AGENTS/LOFEXIDINE
- POSSIBLE QT PROLONGING AGENTS/MACIMORELIN
- POSSIBLE QT PROLONGING AGENTS/INOTUZUMAB OZOGAMICIN
- QT PROLONGING AGENTS/EFAVIRENZ
- POSSIBLE QT PROLONGING AGENTS/HYDROXYZINE
- POSSIBLE QT PROLONGING AGENTS/PIMAVANSERIN
- POSSIBLE QT PROLONGING AGENTS/LENVATINIB
- POSSIBLE QT PROLONGING AGENTS/DELAMANID
- POSSIBLE QT PROLONGING AGENTS/TRAZODONE (>= 100 MG)
- POSSIBLE QT PROLONGING AGENTS/BEDAQUILINE
- QT PROLONGING AGENTS/PASIREOTIDE
- POSSIBLE QT PROLONGING AGENTS/SORAFENIB
- POSSIBLE QT PROLONGING AGENTS/CRIZOTINIB
- POSSIBLE QT PROLONGING AGENTS/EZOGABINE
- POSSIBLE QT PROLONGING AGENTS/GADOFOSVESET
- POSSIBLE QT PROLONGING AGENTS/ERIBULIN
- POSSIBLE QT PROLONGING AGENTS/ROMIDEPSIN
- POSSIBLE QT PROLONGING AGENTS/ILOPERIDONE
- POSSIBLE QT PROLONGING AGENTS/TOREMIFENE
- UGT INHIBITORS/LORAZEPAM; MEXAZOLAM
Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, except as may be authorized by the applicable terms of use.
CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.